Community Engagement & Feedback

The Governmental Advisory Board (GAB) has been established within the EUCanScreen project to provide strategic guidance and expert insights in support of innovative cancer screening strategies across Europe.

We are pleased to announce that representatives from nearly all participating countries have been successfully nominated to the GAB, ensuring a diverse and experienced panel of experts. We are confident that the insights from these candidates will bring valuable perspectives, reflecting the unique needs and challenges of their respective health systems.

The primary role of the GAB is to foster collaboration between policymakers, researchers, and screening program coordinators. Together, we aim to translate scientific recommendations into actionable policies. By leveraging international expertise, the GAB will help bridge gaps in screening implementation, harmonize best practices, and enhance the overall effectiveness of cancer screening programs across Europe.

The inaugural GAB meeting will take place in Turin on the 13th of May, 2025, almost one year after the formal launch of EUCanScreen. During this meeting, we will lay the foundation for our work, discuss key priorities, and define our roadmap for the years ahead. We believe that this initiative will be pivotal in advancing evidence-based screening policies and ensuring equitable access to high-quality cancer screening programs for citizens across Europe.

We are excited to work together to achieve the ambitious goals of EUCanScreen and improve cancer prevention and early detection across the continent.

Authors:
Trude Andreassen  chair of GAB EUCanScreen